Search

Displaying results 2471 - 2480 of 7479 in total
  1. Drug

    Dexrazoxane

    go.drugbank.com/drugs/DB00380
    ApprovedInvestigationalWithdrawn

    An antimitotic agent with immunosuppressive properties. Dexrazoxane, the (+)-enantiomorph of razoxane, provides cardioprotection against anthracycline toxicity. … [PubChem] The Food and Drug Administration has designated dexrazoxane as an orphan drug for use in the prevention or reduction in the incidence and severity of anthracycline-induced cardiomyopathy.

  2. Drug

    LU-31130

    go.drugbank.com/drugs/DB05828
    Experimental

    It acts at the Dopamine D4 receptors in the cortex and has low affinity for D2 receptors, adrenoceptors, muscarinic and histaminergic receptors. … LU-31130 is a rapid acting therapy developed by H. Lundbeck A/S to treat Psychosis, Schizophrenia and Schizoaffective Disorders.

  3. Drug

    Indolidan

    go.drugbank.com/drugs/DB19499
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Indolidan is a cardiac stimulant, pimobendan derivative. Indolidan has a monoisotopic molecular weight of 257.12 Da.

  4. Drug

    Imazodan

    go.drugbank.com/drugs/DB20144
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Imazodan is a cardiac stimulant, pimobendan derivative. Imazodan has a monoisotopic molecular weight of 240.1 Da.

  5. Drug

    Thyromedan

    go.drugbank.com/drugs/DB20438
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Thyromedan is a cardiac stimulant, pimobendan derivative. Thyromedan has a monoisotopic molecular weight of 734.88 Da.

  6. Drug

    Prinoxodan

    go.drugbank.com/drugs/DB21318
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Prinoxodan is a cardiac stimulant, pimobendan derivative. Prinoxodan has a monoisotopic molecular weight of 258.11 Da.

  7. Drug

    Carthamus tinctorius flower bud

    go.drugbank.com/drugs/DB14278
    Approved

    It is not an approved drug.

  8. Drug

    Zanthoxylum clava-herculis whole

    go.drugbank.com/drugs/DB14353
    Approved

    It is not an approved drug.

  9. Drug

    Glafenine

    go.drugbank.com/drugs/DB08963
    ApprovedWithdrawn

    An anthranilic acid derivative with analgesic properties used for the relief of all types of pain. Glafenine is withdrawn from the American market.

  10. Drug

    Ritlecitinib

    go.drugbank.com/drugs/DB14924
    ApprovedInvestigational

    Ritlecitinib (PF-06651600) is a highly selective inhibitor of Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family. In June 2023, it was approved by the FDA for the treatment of severe a...

    Synonyms: 2-propen-1-one, 1-((2S,5R)-2-methyl-5-(7H-pyrrolo(2,3-D)pyrimidin-4-ylamino)-1-piperidinyl)-